TNXP SG&A Expense Growth
Tonix Pharmaceuticals Holding Corp · SG&A Expense Growth
TNXP SG&A Expense Growth
Latest reported113.86%period ending
TNXP FY SG&A Growth (YoY) (0.00% → 113.86%)
Latest values, visible window
High-resolution chart · PNG
TNXP sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 113.8575% | |
| 15.3919% | |
| 15.0157% | |
| 28.7169% | |
| 63.8445% | |
| 34.7029% | |
| 21.3601% | |
| 10.2529% | |
| -23.831% | |
| -17.5541% | |
| 40.0376% | |
| 44.9022% | |
| 52.9633% | |
| 83.6684% | |
| 16,078.6724% | |
| -1.0241% | |
| -1.1196% | |
| 0% |